Public list Pharma Startups (4743):
MIDA, LLC is a research and development drug therapeutic company focused on infectious disease indications.
Company (Alive / Active)
|Investor||Investor Type||Location||Participating Rounds|
|Vancouver, British Columbia, Canada||Alive / Active||Inimex Pharmaceuticals, Inc. is focused on the development and commercialization of Innate Defense Regulators (IDRs), first in class drugs that selectively trigger the body's innate defenses without causing inflammation. IDR products have major market potential for infectious disease, cancer, and inflammatory disease. These products will reduce morbidity and mortality in the rapidly growing population of immune suppressed and elderly patients who are "at-risk" for these disorders. IDR produc...Show all||Login to see details|
|Seattle, Washington, United States||Acquired||Immune Design is a clinical-stage biotechnology company developing two synergistic platforms of vaccines designed to treat cancer, infectious diseases, allergy, and autoimmune disorders. The company employs technologies that target dendritic cells for more precise activation of the immune response. These include DCVex, a lentiviral vector platform engineered to deliver antigen-encoding nucleic acids directly to dendritic cells in vivo, and GLAAS, a TLR4 agonist platform that activates dendritic ...Show all||Login to see details|
|Title||Application Date||Patent Date||Status
(Patent / Application)